PROTEINS, GENES AND THEIR USE FOR DIAGNOSIS AND TREATMENT OF MULTIPLE SCLEROSIS

WIPO Patent Application WO2002059604

A8

The present invention provides methods and compositions for screening, diagnosis and prognosis of Multiple Sclerosis, for monitoring the effectiveness of Multiple Sclerosis treatment, identifying patients most likely to respond to a particular therapeutic treatment and for drug development. Multiple Sclerosis-Associated Features (MSFs), detectable by two-dimensional electrophoresis of body fluid e.g. cerebrospinal fluid are described. The invention further provides Multiple Sclerosis-Associated Protein Isoforms (MSPIs) detectable in body fluid e.g. cerebrospinal fluid, preparations comprising isolated MSPIs, antibodies immunospecific for MSPIs, and kits comprising the aforesaid.

JP3499570	INDUSTRIAL APPLICABILITY: Receptor binding assay for detecting TSH receptor autoantibodies.
JP6388284	Lipidomic biomarkers for predicting cardiovascular outcomes in patients with coronary artery disease receiving statin treatment
WO/2005/021739	ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR

HERATH HERATH MUDIYANSELAGE AT (GB)
PAREKH RAJESH BHIKHU (GB)
ROHLFF CHRISTIAN (GB)

PCT/GB2002/000330

November 21, 2002

January 25, 2002

Click for automatic bibliography generation  

OXFORD GLYCOSCIENCES UK LTD (GB)
HERATH HERATH MUDIYANSELAGE AT (GB)
PAREKH RAJESH BHIKHU (GB)
ROHLFF CHRISTIAN (GB)

G01N33/53; A61K31/7088; A61K38/00; A61K39/395; A61K48/00; A61P25/00; C07K14/47; C07K16/18; C07K16/46; C12N15/09; C12P21/08; C12Q1/02; C12Q1/68; G01N33/15; G01N33/483; G01N33/50; G01N33/566; G01N33/68; (IPC1-7): G01N33/564; A61K39/00; A61P25/00

View/Download PDF      PDF Help

Previous Patent: MICRODEVICES CONTAINING PHOTORECOGNIZABLE CODING PATTERNS AND METHODS OF USING AND PRODUCING THE SAM...

Next Patent: METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE